Abstract:It is well-recognized that glycemic disorders are leading causes of diabetic complications and acute fluctuation of blood glucose and reported more likely being related to oxidative stress, vasculopathy, and other diabetic complications than continuous hyperglycemia in patients with diabetic and animal models. To explore the hypothesis that acute glucose fluctuation (GF) aggravates inflammatory lesions and neuron apoptosis in the hippocampus of diabetic rats. Twenty female GK rats were randomly allocated into a glucose fluctuating group (GK-GF) and a continuous hyperglycemia group (GK-CHG) and 10 age-matched female Wistar rats served as controls. GF was induced in the GK-GF group by injection with glucose and insulin at different periods of time per day for 6 weeks. Body weight was determined weekly. At the end of the study, blood hemoglobin A1c (HbA1c) and serum lipids were measured. Serum and hippocampus interleukin 1 beta (IL-1 beta), IL-6, IL-8, and tumor necrosis factor-alpha (TNF-alpha) were measured by enzyme-linked immunosorbent assay and real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Hippocampus Bcl-2, Bax, Pten, fas, and myc were quantified by qRT-PCR and Western blot analysis and Mirror Water Maze (MWM) test was performed. We successfully established an animal model with daily GF and a control model with CHG using GK diabetic rats. The GF and CHG rats showed lower weight gain during the 6-week experimental period with no significant difference in the levels of serum lipids such as total triglyceride, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol compared with the control rats at the end of the study. Meanwhile, the GF and CHG rats showed higher blood HbA1c levels than that of control rats. MWM trainings tests detected that glucose disorders in GF and CHG rats tend to present longer latencies, more cross times and longer path length compared with those of the control rats, indicating impaired the hippocampus-regulated behavioral function such as spatial orientating and memory. Importantly, it was found that GF promoted the expression of TNF-alpha and IL-1 beta in the hippocampus of the GF rats while continuous hyperglycemia in CHG rats had little effect on that. Furthermore, both GF and CHG diabetic rats had abnormal expression of apoptosis-associated genes in the hippocampus compared with control Wistar rats and neurons apoptosis in GF rats appears to be more severe than CHG rats. Overall, this study confirmed that GF is a more critical factor that would promote the neuron apoptosis and induce inflammation in the hippocampus than continuous hyperglycemia in diabetic animals, which shed new light on the importance of monitoring and administration of blood glucose in the prevention and therapy for diabetes.

Effects of Insulin on Cognitive Impairment and GFAP Expression of Cerebral Astrocytes in Diabetic Rats

Expression Changes of Growth-Associated Protein-43 (Gap-43) and Mitogen-Activated Protein Kinase Phosphatase-1 (Mkp-1) and in Hippocampus of Streptozotocin-Induced Diabetic Cognitive Impairment Rats

[The Investigation of Syn and NPY Expression in Brain Tissues of Diabetic Model Rat Induced by Streptozotocin].

Changes in the Expression of Platelet-Derived Growth Factor in Astrocytes in Diabetic Rats with Spinal Cord Injury

Acute Glucose Fluctuation Induces Inflammation and Neurons Apoptosis in Hippocampal Tissues of Diabetic Rats.

Improvement of insulin on learning and memory impairment by decreasing content of glutamate and D-serine in hipocampus of diabetic rats

Intranasal Insulin Ameliorates Cerebral Hypometabolism, Neuronal Loss, and Astrogliosis in Streptozotocin-Induced Alzheimer’s Rat Model

Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer’s rat model

Insulin treatment restores glutamate (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor function in the hippocampus of diabetic rats

Effect of Diabetes on Spatial Memory Ability in Rats Using Morris Water Maze

Insulin aggravates amyloid deposition and cognition impairment in an AD-like rat model

Effect and Mechanism of Auricularia Auriculajudae Polysaccharide in Hippocampus of Streptozotocin‐induced Diabetic Cognitive Impairment Rats

A PRILIMINARY STUDY ON THE EFFECT OF IODOACETAMIDE AND INSULIN IN THE RAT MODEL OF ALZHEIMER'S DISEASE

Insulin Therapy Restores Impaired Function and Expression of P-glycoprotein in Blood–brain Barrier of Experimental Diabetes

Ameliorative Effects of Angiotensin-Iv on the Expression of Hippocampus Synaptophysin and the Cognitive Function of Diabetic Rats

Blood-Brain Barrier Disruption Induced Cognitive Impairment Is Associated With Increase of Inflammatory Cytokine.

Influence of increased blood glucose level on brain iniurv after hvpoglvcemia in rats

Effect of Diabetes on Expression of Intercellular Adhesion Molecule-1 and Injury of Brain Tissue and Blood-Brain Barrier in Cerebral Ischemia Rats

Effect of Astragalus Polysacharin on the cognitive function of diabetic rats

Alteration of interaction between astrocytes and neurons in different stages of diabetes: a nuclear magnetic resonance study using [1-(13)C]glucose and [2-(13)C]acetate

Relationship Between Insulin Sensitivity Index and Cognitive Function in Diet-Induced Insulin Resistant Rats.